Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tilray (TSE:TLRY)
TSX:TLRY
TLRY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$1.21 - C$4.00
Previous CloseN/A
Volume1.39M
Average Volume (3M)1.51M
Market Cap
$1.19B
Enterprise ValueC$1.26B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.83
Next Earnings
Apr 15, 2025EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding937,655,200
10 Day Avg. Volume1,970,005
30 Day Avg. Volume1,510,365
Standard Deviation0.22
R-Squared0.24
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.01
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.38Price Target Upside93.75% Upside
Rating ConsensusHold
Number of Analyst Covering8
---
Bulls Say, Bears Say
Bulls Say
Beverage SegmentBeverage Improvement Plans are back on track with internalized production and focus on core markets, resulting in significant cost savings.
Facility ImprovementsThe company recently completed capital investments in a facility that allows better use of byproducts for vapes and infused pre-rolls, expected to improve Canadian adult-use trends.
Bears Say
Canadian Market ChallengesCanadian adult-use will be challenging due to price competition.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.61% Insiders
0.41% Mutual Funds
1.79% Other Institutional Investors
94.89% Public Companies and Individual Investors
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was C$1.21 and its highest was C$4.00 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $1.19B.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Apr 15, 2025 which is in 52 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Jan 10, 2025. The company reported -C$0.142 earnings per share for the quarter, missing the consensus estimate of -C$0.048 by -C$0.094.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.06.
How many shares outstanding does Tilray have?
Tilray has 937,655,200 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -C$0.142 in its last earnings report, missing expectations of -C$0.048. Following the earnings report the stock price went down -12.06%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TSE:TLRY
---
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
C$2.38 (93.75% Upside)
C$2.38 (93.75% Upside)
Blogger Sentiment
Bullish
TSE:TLRY Sentiment 84%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $35.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.53%
12-Months-Change
Fundamentals
Return on Equity
-7.28%
Trailing 12-Months
Asset Growth
-3.21%
Trailing 12-Months
Company Description
Tilray
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
---
TLRY Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and successful expansion in the beverage and international cannabis segments. However, these positives were tempered by significant net loss and challenges in the Canadian cannabis market, as well as impacts from SKU rationalization. Though there are promising growth areas, the financial setbacks and market challenges balance the overall sentiment.Read More>---
TLRY Stock 12 Month Forecast
Average Price Target
C$2.38
▲(93.75% Upside)
Technical Analysis
Best Analysts Covering TLRY
1 Year
1 Year Success Rate
2/15 ratings generated profit
1 Year Average Return
-40.75%
reiterated a buy rating last month
Copying Owen Bennett's trades and holding each position for 1 Year would result in 13.33% of your transactions generating a profit, with an average return of -40.75% per trade.
---